0.1197USD-54.68%Mkt Cap: 4.18M USDP/E: —Last update: 2026-06-03
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operate…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap4.18M USD
Enterprise Value482.56M USD
Revenue (TTM)507.36M USD
Gross Profit120.98M USD
Net Income (TTM)-68.63M USD
Revenue/Share14.73 USD
Last Price0.1197 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.9K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS45783Q1004
Valuation
P/E (Trailing)—
P/E (Forward)-5.72
PEG—
EV/EBITDA56.38
EV/Revenue0.95
P/S0.02
P/B0.13
EPS (TTM)-2.48
EPS (Forward)-0.05
52W Range
0.10241% of range3.320
52W High3.320 USD
52W Low0.1024 USD
Profitability
Gross Margin23.58%
Oper. Margin-16.03%
EBITDA Margin1.69%
Profit Margin-13.38%
ROE-50.45%
ROA-8.90%
Growth
Revenue Growth-5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.46M USD
CapEx (TTM)16.61M USD
FCF Margin4.66%
FCF Yield565.61%
Net Debt472.59M USD
Net Debt/EBITDA55.22
Balance Sheet
Debt/Equity3.38
Current Ratio0.27
Quick Ratio0.15
Book Value/Sh2.210 USD
Cash/Share0.4350 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.250 USD
Target Range1.500 USD – 5.000 USD
# Analysts2
Ownership
Shares Out.34.89M
Float32.32M
Insiders9.02%
Institutions14.00%
Short Interest
Short Ratio2.5d
Short % Float9.47%
Short % Out.8.72%
Shares Short3.04M
Short (prev mo.)2.72M
Technical
SMA 500.2874 (-58.4%)
SMA 2000.7955 (-85.0%)
Beta3.83
S&P 52W Chg27.94%
Avg Vol (30d)1.44M
Avg Vol (10d)806.98K
Technical Indicators
RSI (14)27.3
MACD-0.0166
MACD Signal-0.0074
MACD Hist.-0.0092
BB Upper0.3544 USD
BB Middle0.2735 USD
BB Lower0.1926 USD
BB Width59.18%
ATR (14)0.0413 USD
Vol Ratio (20d)25.61x